Literature DB >> 30573809

Renal denervation reduces sympathetic overactivation, brain oxidative stress, and renal injury in rats with renovascular hypertension independent of its effects on reducing blood pressure.

Erika E Nishi1, Nathalia R Lopes2, Guiomar N Gomes2, Juliana C Perry3, Alex Y S Sato2, Maria G Naffah-Mazzacoratti4, Cássia T Bergamaschi2, Ruy R Campos2.   

Abstract

The underlying mechanisms by which renal denervation (RD) decreases blood pressure (BP) remain incompletely understood. In this study, we investigated the effects of ischemic kidney denervation on different sympathetic outflows, brain and renal expression of angiotensin-II receptors, oxidative stress and renal function markers in the 2-kidney, 1-clip (2K-1C) rat model. Surgical RD was performed in Wistar male rats 4-5 weeks after clip implantation. After 10 days of RD, BP, and the activity of sympathetic nerves projecting to the contralateral kidney (rSNA) and splanchnic region were partially reduced in 2K-1C rats, with no change in systemic renin-angiotensin system (RAS). To distinguish the effects of RD from the reduction in BP, 2K-1C rats were treated with hydralazine by oral gavage (25 mg/kg/day for 1 week). RD, but not hydralazine, normalized oxidative stress in the sympathetic premotor brain regions and improved intrarenal RAS, renal injury, and proteinuria. Furthermore, different mechanisms led to renal injury and oxidative stress in the ischemic and contralateral kidneys of 2K-1C rats. Injury and oxidative stress in the ischemic kidney were driven by the renal nerves. Although RD attenuated rSNA, injury and oxidative stress persisted in the contralateral kidney, probably due to increased BP. Therefore, nerves from the ischemic kidney at least partially contribute to the increase in BP, sympathetic outflows, brain oxidative stress, and renal alterations in rats with renovascular hypertension. Based on these findings, the reduction in oxidative stress in the brain is a central mechanism that contributes to the effects of RD on Goldblatt hypertension.

Entities:  

Keywords:  Hypertension; Oxidative stress; Renal nerves

Year:  2018        PMID: 30573809     DOI: 10.1038/s41440-018-0171-9

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  9 in total

1.  Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials.

Authors:  Yukako Ogoyama; Kazuhiro Tada; Makiko Abe; Shinsuke Nanto; Hirotaka Shibata; Masashi Mukoyama; Hisashi Kai; Hisatomi Arima; Kazuomi Kario
Journal:  Hypertens Res       Date:  2021-10-17       Impact factor: 5.528

Review 2.  Patient Selection for Renal Denervation in Hypertensive Patients: What Makes a Good Candidate?

Authors:  Sheran Li; Jacqueline K Phillips
Journal:  Vasc Health Risk Manag       Date:  2022-05-13

3.  Melatonin attenuates renal sympathetic overactivity and reactive oxygen species in the brain in neurogenic hypertension.

Authors:  Erika E Nishi; Vitor R Almeida; Fernanda G Amaral; Karin A Simon; Henrique A Futuro-Neto; Roberto B Pontes; Juliana G Cespedes; Ruy R Campos; Cássia T Bergamaschi
Journal:  Hypertens Res       Date:  2019-07-17       Impact factor: 3.872

4.  Strength Training Reduces Cardiac and Renal Oxidative Stress in Rats with Renovascular Hypertension.

Authors:  Rodrigo Miguel-Dos-Santos; Jucilene Freitas Dos Santos; Fabricio Nunes Macedo; Anderson Carlos Marçal; Valter J Santana Filho; Rogerio Brandão Wichi; Sandra Lauton-Santos
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

5.  Renal Sensory Activity Regulates the γ-Aminobutyric Acidergic Inputs to the Paraventricular Nucleus of the Hypothalamus in Goldblatt Hypertension.

Authors:  Maycon I O Milanez; Amanda C Veiga; Beatriz S Martins; Roberto B Pontes; Cassia T Bergamaschi; Ruy R Campos; Erika E Nishi
Journal:  Front Physiol       Date:  2020-12-15       Impact factor: 4.566

6.  Melatonin as a rational alternative in the conservative treatment of resistant hypertension.

Authors:  Fedor Simko; Russel J Reiter; Ludovit Paulis
Journal:  Hypertens Res       Date:  2019-09-13       Impact factor: 3.872

7.  Involvement of Neuropeptide Y within Paraventricular Nucleus in Electroacupuncture Inhibiting Sympathetic Activities in Hypertensive Rats.

Authors:  Qi Zhang; Yingying Tan; Xin Wen; Fangfang Li
Journal:  Int J Hypertens       Date:  2022-01-18       Impact factor: 2.420

Review 8.  Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors.

Authors:  Hajaralsadat Hosseini-Dastgerdi; Fatemeh Kharazmi; Ali-Asghar Pourshanazari; Mehdi Nematbakhsh
Journal:  Int J Nephrol       Date:  2022-10-10

9.  Resveratrol in the Hypothalamic Paraventricular Nucleus Attenuates Hypertension by Regulation of ROS and Neurotransmitters.

Authors:  Jie Qi; Li-Yan Fu; Kai-Li Liu; Rui-Juan Li; Jin-An Qiao; Xiao-Jing Yu; Jia-Yue Yu; Ying Li; Zhi-Peng Feng; Qiu-Yue Yi; Hong Jia; Hong-Li Gao; Hong Tan; Yu-Ming Kang
Journal:  Nutrients       Date:  2022-10-07       Impact factor: 6.706

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.